Prescott Group Capital Management L.L.C. lifted its position in Cardlytics Inc (NASDAQ:CDLX) by 16.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,000 shares of the company’s stock after purchasing an additional 5,000 shares during the quarter. Prescott Group Capital Management L.L.C.’s holdings in Cardlytics were worth $876,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. California State Teachers Retirement System acquired a new stake in Cardlytics during the first quarter worth about $122,000. Wells Fargo & Company MN grew its holdings in Cardlytics by 72.4% during the third quarter. Wells Fargo & Company MN now owns 8,004 shares of the company’s stock worth $201,000 after acquiring an additional 3,361 shares during the period. Schwab Charles Investment Management Inc. acquired a new stake in Cardlytics during the second quarter worth about $214,000. Rockefeller Capital Management L.P. acquired a new stake in Cardlytics during the third quarter worth about $231,000. Finally, Bank of New York Mellon Corp grew its holdings in Cardlytics by 32.9% during the second quarter. Bank of New York Mellon Corp now owns 15,553 shares of the company’s stock worth $338,000 after acquiring an additional 3,846 shares during the period. Hedge funds and other institutional investors own 60.76% of the company’s stock.
CDLX has been the topic of several research analyst reports. Zacks Investment Research raised Cardlytics from a “hold” rating to a “buy” rating and set a $16.00 price objective on the stock in a report on Monday, November 19th. Raymond James dropped their price objective on Cardlytics from $23.00 to $20.00 and set an “outperform” rating on the stock in a report on Wednesday, November 14th. JPMorgan Chase & Co. dropped their price objective on Cardlytics from $31.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, November 14th. Morgan Stanley dropped their price objective on Cardlytics from $28.00 to $26.00 and set an “overweight” rating on the stock in a report on Wednesday, November 14th. Finally, SunTrust Banks reissued a “buy” rating and issued a $27.00 price objective on shares of Cardlytics in a report on Tuesday, September 11th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $23.25.
Shares of CDLX opened at $14.79 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 3.04 and a current ratio of 3.04. Cardlytics Inc has a 12 month low of $11.10 and a 12 month high of $28.29.
Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings data on Tuesday, November 13th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.63) by $0.48. The business had revenue of $34.58 million during the quarter, compared to analyst estimates of $37.62 million. Cardlytics’s quarterly revenue was up 10.1% compared to the same quarter last year. Analysts anticipate that Cardlytics Inc will post -2.08 earnings per share for the current fiscal year.
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
Featured Story: Balanced Fund
Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics Inc (NASDAQ:CDLX).
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.